跳至主要内容
临床试验/CTRI/2024/03/063715
CTRI/2024/03/063715尚未招募Phase 3 4

Efficacy of Platelet Rich Plasma in treatment of knee osteoarthritis: A single group Pre & Post intervention QUASI Experimental study.

JLN Medical College1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2024年3月18日最近更新:

试验速览

阶段
Phase 3 4
状态
尚未招募
发起方
入组人数
80
试验地点
1
主要终点
pain will be assessed by WOMEC score and Visual Analogue Score

研究概览

简要总结

80 participants who will meet the inclusion criteria and giving informed written consent will be evaluated for their WOMAC score and radiological grading of knee joint. Under all aseptic precautions PRP will be prepared by taking 22 ml venous blood in single use PRP kit (PrecureCellTM) and single spin method at 3500 RPM for 15 minutes. PRP will be injected immediately after preparation to prevent any contamination. Under aseptic conditions, ultrasound guided Intraarticular injection through the suprapatellar approach 8 mL of platelet concentrate will be injected into a suprapatellar pouch through a supero lateral approach with an 22-gauge needle. The knees were immobilized for 10 min after injection. Data will be collected including baseline WOMAC score (Western Ontario and McMaster Universities Osteoarthritis Index) by an independent observer in each knee. Patient will be lied down in supine position for 2 h and monitored for HR, BP, SPO2 and any adverse events. Patients will be evaluated on 6 week, 3 months and 6 months after the first injection by a blinded observer for change in WOMAC score. Data will be collected and analysed using standard tests and p value of less than 0.05 will be considered significant

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
45.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Patients aged 45-65 years with either side OA knees (ASA class I and II) of either gender History of pain in last month Those with imaging findings (X-ray) of degenerative changes of the joint without significant deformity (diagnosed by KL classification ( Grade 2 and 3).

排除标准

  • Patients with KL grading I ( doubtful disease) and grade 4 (Severe disease) Patient with history of diabetes mellitus On Immunosuppressive drugs Collagen vascular disorders Cancer or malignant disorders Active infection/ wound of knee Patients with autoimmune and platelet disorders Treatment with anticoagulant and antiplatelet medications within 10 days before injection Use of NSAIDs within 2 days before injection or unwilling to stop then post injection except paracetamol History of knee articular injection of corticosteroid during previous 3 months or use of systemic corticosteroids 2 weeks before PRP injection Patients with genu valgum/Varum greater than 20 degrees Human immunocompromised virus, Hepatitis B virus, Hepatitis C virus, venereal Disease Research Laboratory virus positive cases Knee surgery on affected side within last 12 months Systemic or inflammatory knee disease Presence of warm and tense joint effusion High chances of loss of follow-up History of trauma to affected knee.

结局指标

主要结局

pain will be assessed by WOMEC score and Visual Analogue Score

时间窗: Patients will be evaluated | on 6 week, 3 months and 6 months after the first injection by a blinded observer | for change in WOMAC score

次要结局

  • VAS score(at baseline/ 6 week / 3 month and 6 months)

研究者

发起方
JLN Medical College
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Veena Mathur

JLN Medical College Ajmer

研究点 (1)

Loading locations...

相似试验